Description: Immunoprecise Antibodies Ltd, formerly Tanqueray Exploration Ltd, is a Canada-based supplier of custom hybridoma development services. The Company's geographical segments include United States of America and Canada. It offers products, such as antibodies and hybridoma licensing. It offers various services, such as ImmunoProtect, Monoclonal Development, Polyclonal Development, Antibody Protection, Peptide Production and Cryopreservation Services. Its antibody products include IPA006A, IPA006B and IPA006F, which it offers to the research and industrial community. Its hybridoma licensing products include Anti-Human P38a (MAPKinase) Monoclonal Antibody Hybridoma Cell Line and Anti-Acetylated Lysine Monoclonal Antibody Hybridoma Cell Line. It offers cryopreservation storage service for the secure storage of users' valuable biological materials, including hybridoma clones, plasmid constructs and cell lines. It also offers both peptide synthesis and protein carrier conjugation services.
Home Page: www.ipatherapeutics.com
IPA Technical Analysis
3204–4464 Markham Street
Victoria,
BC
V8Z 7X8
Canada
Phone:
250 483 0308
Officers
| Name | Title |
|---|---|
| Dr. Jennifer Lynne Bath Ph.D. | CEO, Pres & Non-Independent Director |
| Mr. Brad McConn | Chief Financial Officer |
| Dr. Ilse Roodink | Chief Scientific Officer |
| Mr. David E. Orton | Chief Operating Officer |
| Ms. Carla Dahl | VP of Marketing |
| Dr. Barry Neil Duplantis | VP of Client Relations |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4468 |
| Price-to-Sales TTM: | 8.3267 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 85 |